Connect with us

Health

COVID-19-Related Deaths Fewer in Africa—WHO

Published

on

UK COVID-19 Variant

By Adedapo Adesanya

A new World Health Organisation (WHO) pandemic assessment has found out that despite an 83 per cent surge in new COVID-19 cases during the past week in Africa, driven by the Delta and the Omicron variants, fewer deaths have been recorded than in the previous surges.

It, however, warned that more waves could be building as updated forecasts warn that the continent may not reach 70 per cent vaccine coverage until August 2024.

According to the report, Africa recorded more than 196,000 new cases for the week ending December 12, up from around 107,000 in the previous week, bringing the total cumulative number of recorded cases during the pandemic to 8.9 million.

The number of new COVID-19 cases is currently doubling every five days, the shortest reported this year while the speed of the spread is fast, deaths remain low and even dropped by 19 per cent last week compared with the previous week.

There were a little over 3,000 COVID-19-related deaths reported during the first three weeks of the current pandemic wave, which is Africa’s fourth.

WHO explained that about half as many cases were reported in the same time frame during the third wave which was fuelled by the Delta variant.

This upsurge in new cases coupled with low hospitalizations is particularly marked in South Africa which has experienced a 66 per cent rise in new cases during the past seven days compared with the previous seven days.

It noted that hospitalizations have increased by 67 per cent in the past seven days, the bed occupancy rate for Intensive Care Units remains low at 7.5 per cent with 14 per cent of the hospitalized patients receiving supplemental oxygen.

Though the deaths also remain low, WHO warned that the data should be interpreted with caution as the pattern may change in the coming weeks.

“We are cautiously optimistic that deaths and severe illness will remain low in the current wave, but slow vaccine rollout in Africa means both will be much higher than they should be,” said Dr Matshidiso Moeti, WHO Regional Director for Africa.

“We’ve known for quite some time now that new variants like Beta, Delta or Omicron could regularly emerge to spark new outbreaks globally, but vaccine-deprived regions like Africa will be especially vulnerable.”

Vaccination coverage remains highly variable across the region. As of 13 December, only 20 African countries had vaccinated at least 10 per cent of their population—the global target WHO had set for September 2021.

Only six countries have hit the year-end target of fully vaccinating 40 per cent of their population, while only two countries—Mauritius and Seychelles—have reached the 70 per cent coverage seen as essential for controlling the pandemic.

At the current pace, WHO estimates that it will take until May of 2022 before Africa reaches 40 per cent coverage and August 2024 before it reaches the 70 per cent mark.

“In a world where Africa had the doses and support to vaccinate 70 per cent of its population by the end of 2021—a level many wealthy countries have achieved—we probably would be seeing tens of thousands of fewer deaths from COVID-19 next year.

“But we can still save many lives if we can accelerate the pace of vaccination in early 2022,” he added.

WHO data show that 53 African countries have initiated vaccination programmes, which have administered a total of 264 million doses (or 61 per cent of doses received).

Fully vaccinating 70 per cent of Africans requires about 1.6 billion more doses and strengthened efforts to increase vaccine demand.

Dr Moeti added that, “We’re at a pivotal moment in this pandemic where complacency is the enemy. With supplies starting to increase we now must intensify our focus on other barriers to vaccination. They include lack of funding, equipment, healthcare workers and cold chain capacity along with tackling vaccine hesitancy.”

According to the WHO Africa COVID-19 readiness dashboard, of the 34 countries that have submitted complete data, 28 countries (80 per cent) have engaged provinces and districts in preparations for vaccinations; 32 countries (91 per cent) have conducted national training initiatives, and 29 countries (82 per cent) have trained district vaccinators and volunteers.

To increase vaccination coverage, WHO is encouraging countries to move vaccination sites beyond health facilities and main cities and implement community-centred approaches. In an analysis of data collected from 40 countries, six countries confirmed having districts with no vaccination sites.

Meanwhile, Africa’s vaccine challenges are being compounded by Omicron-related travel bans.

Globally, there have been more than 2700 Omicron cases reported in 59 countries, including 11 African countries that account for about 33 per cent of the total cases.

However, Africa’s share is steadily dropping, and South Africa no longer leads the world in Omicron cases. Yet more than 70 countries continue to impose travel bans mainly targeting African countries.

In addition to vaccination coverage, WHO’s 2022 COVID-19 strategy for Africa includes a strong focus on surveillance aimed at increasing case detection, strengthening genomic surveillance to track new variants of concern as well as country capacity for appropriate case management including home-based isolation and care, and guarding against COVID-19 with key preventive measures amidst reduced risk perception.

Adedapo Adesanya is a journalist, polymath, and connoisseur of everything art. When he is not writing, he has his nose buried in one of the many books or articles he has bookmarked or simply listening to good music with a bottle of beer or wine. He supports the greatest club in the world, Manchester United F.C.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Tinubu Chooses Obi Adigwe Coordinator of Health Tech Data Analytics Office

Published

on

obi adigwe

By Modupe Gbadeyanka

Dr Obi Adigwe has been appointed as the pioneer National Coordinator of the National Health Technology and Data Analytics Office (NHTDAO).

The body was created by the Ministry of Health under the approval of President Bola Tinubu.

NHTDAO will be domiciled in the Office of the Coordinating Minister of Health and Social Welfare, a statement on Friday by the Special Adviser to the President on Information and Strategy, Mr Bayo Onanuga, stated.

The agency will serve as a meta-level national platform for coordinating the country’s digital-health agenda. It will reinforce, not replace, the existing statutory functions of relevant departments and agencies, it was emphasised.

The organisation will also harmonise and empower the public and private institutions across the health system, set the standards that connect them, and operationalise the National Digital Health Architecture, approved by the National Council on Health in November 2025.

It was stated that President Tinubu expects NHTDAO to accelerate Nigeria’s transition to a secure, interoperable and data-driven health system that improves outcomes for all citizens.

Mr Adigwe, as Director General of the National Institute for Pharmaceutical Research and Development, has leveraged science to catalyse interventions in artificial intelligence, translational research, and technology transfer.

He coordinated major projects, including the ¥300m Nanotechnology grant and the AFREXIMBank grant for Africa’s first API Training Facility. He led the roadmap development that underpinned an €18 million EU grant, the largest in Africa for the thematic area. During the last pandemic, Adigwe globally showcased African science by undertaking the world’s first analysis to debunk claims about the Covid Organics preparation.

The Office’s Steering Committee, which provides strategic direction and oversight, comprises:

  • Professor Muhammad Ali Pate, Coordinating Minister of Health and Social Welfare (Co-chair)
  • Mr Olaniyi Yusuf, Chairman of the Nigerian Economic Summit Group (Co-chair)
  • Dr Iziaq Adekunle Salako, Minister of State for Health and Social Welfare (Alternate Co-chair)
  • Ms Kachollom Daju, Permanent Secretary, Federal Ministry of Health and Social Welfare
  • Mr Idris Alubankudi Saliu, Special Adviser to the President on Technology and Digital Economy
  • Dr Muntaqa Umar-Sadiq, National Coordinator, SWAp Coordination Office
  • Dr Abdu Mukhtar, National Coordinator, Presidential Initiative to Unlock Healthcare Value Chain
  • Dr Muyi Aina, Executive Director, National Primary Health Care Development Agency
  • Dr Kelechi Ohiri, Director General, National Health Insurance Authority
  • Director, Health Planning, Research and Statistics, Ministry of Health and Social Welfare
  • National Information Technology Development Agency Representative
  • Six representatives of the State Commissioners of Health, one from each of the six geopolitical zones
  • Pharm Hamza Buhari, Stakeholder representing Industry and Community.
Continue Reading

Health

Lagos Commences Screening of Newborns for Sickle Cell Disease

Published

on

sickle cell disease screening Lagos

By Modupe Gbadeyanka

The Lagos State government has kicked off an initiative to ensure that every newborn is screened for Sickle Cell Disease within 48 to 72 hours after birth using a simple heel-prick test.

It was gathered that babies identified as being at risk will immediately be placed on preventive care while awaiting confirmatory testing.

The Head of the Haematology Department at the Alimosho General Hospital, Dr Olubukola Orolu, revealed that an estimated 150,000 babies are born annually with Sickle Cell Disease in Nigeria, giving the country one of the highest SCD burdens globally.

She, however, applauded the Lagos State Government and the Clinton Health Access Initiative (CHAI) for introducing the state-wide newborn screening programme, describing it as a major step towards reducing childhood deaths associated with the disease.

The commencement of this scheme coincides with the 2026 World Sickle Cell Day, themed Young Voices Rising for Sickle Cell Disease – Closing the Survival Gap: Equity in Sickle Cell Disease.

It highlights the importance of listening to the experiences and aspirations of young people living with Sickle Cell Disease.

Mrs Orolu noted that SCD warriors are increasingly breaking barriers as advocates, leaders, students and change-makers, adding that their voices have continued to reshape the narrative through advocacy for equitable, patient-centred healthcare, self-care and experience sharing.

She, therefore, called for equal access to quality healthcare, survival opportunities and dignity for everyone living with Sickle Cell Disease.

Also commenting, the chief executive of Alimosho General Hospital, Dr Akinyele Akinlade, described Sickle Cell Disease as an inherited blood disorder that is not contagious, noting that individuals living with the condition are more susceptible to infections.

He advised SCD warriors to stay well hydrated, avoid stress, and protect themselves from extreme cold or heat, as these are common triggers of sickle cell crises, adding that these preventive measures can significantly reduce the frequency and severity of crises.

One of the participants, Ms Borokini Zainab, an SCD warrior and student nurse, expressed appreciation to the organisers for the enlightenment programme.

Sharing her personal journey, she spoke about the challenges of balancing recurrent pain crises with her academic pursuits and personal life. Despite moments of frustration, she encouraged fellow warriors not to lose hope.

“Don’t let sickle cell put you down. Be encouraged from within. Don’t let your dreams be shattered because of this,” she said, adding that her personal experience with Sickle Cell Disease inspired her to pursue a career in nursing so she could support others living with the condition.

Continue Reading

Health

Evon Labs Unveils Health-Tech Incubation Initiative HealthX Catalyst

Published

on

Evon Labs Isioma Udeozo HealthX Catalyst

By Aduragbemi Omiyale

A 12-week health-tech incubation programme tailored for early-stage founders in Nigeria has been introduced by an innovation and venture-building platform, Evon Labs.

This initiative, known as HealthX Catalyst, will help participants to create scalable, investable solutions for Africa’s urgent healthcare issues.

The programme is underway, with 12 selected founders nearing the final weeks of intensive incubation, ending with a Demo Day on June 24, 2026, at the UNDP innovation centre in Lagos, where the small business owners will present their solutions to an audience of investors, healthcare leaders, development organisations, and technology partners.

The initiative selects early-stage healthcare founders and immerses them in a structured 12-week development process. Throughout this period, participants receive personalised and group mentorship from seasoned professionals across the healthcare, technology, and business sectors.

They also receive structured support for startup development, including refining business models, developing value propositions, and validating markets.

Additionally, participants gain access to a network of healthcare practitioners, sector experts, and industry leaders, along with targeted investment-readiness assistance to prepare them to engage with investors and strategic partners after the programme.

The result is a cohort of founders who move through the programme not simply with a refined pitch, but with a validated business model, a stronger professional network, and a clear pathway to growth.

To accelerate the most promising solutions beyond the programme, monetary grants will be awarded to the top three founders to support product development, pilot implementation, market validation, and early-stage scaling.

It was learned that HealthX Catalyst was developed in response to a structural gap in the African health-tech ecosystem.

Across the continent, a growing number of entrepreneurs are building solutions to healthcare problems from access and diagnostics to service delivery and health data infrastructure. Yet many of these early-stage ideas fail to progress beyond concept, not for lack of vision, but for lack of structured support: mentorship, startup development frameworks, industry access, and early-stage funding pathways. HealthX Catalyst was built to provide exactly that.

“Africa does not have a shortage of healthcare innovators. What it has lacked is the infrastructure to turn its ideas into sustainable businesses. HealthX Catalyst is that infrastructure, a serious, structured programme designed to take founders from early-stage ideas to investable startups.

“What we are seeing from this first cohort is exactly what we set out to create: founders who are not just building products, but building businesses that can scale and create lasting impact,” the founder of Evon Labs, Ms Isioma Udeozo, said of the unveiling of HealthX Catalyst.

The partners of the programme are the United Nations Development Programme (UNDP), Odua Investment Company Limited (OICL), Washington University of St Louis, Missouri, Lagos State Employment Trust Fund (LSETF), and Brooks Insights.

Continue Reading

Trending